9robes

9robes

Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., Docket No. 24-889

5 min · Ayer
Portada del episodio Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., Docket No. 24-889

Descripción

This ruling protects generic drug competition while still holding companies accountable if they cross the line into deliberately promoting patented uses. For patients and consumers, it means generic drugs will remain a competitive force in the market. For brand-name companies, it means they need clear evidence of intentional wrongdoing, not just circumstantial suggestions, to win these lawsuits. music for the podcast provided by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Dimitry Taras [https://pixabay.com/music/upbeat-upbeat-energetic-rock-fun-happy-travel-background-254065/]

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de 9robes!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

149 episodios